4.7 Article

Decreased striatal adenosine A2A-dopamine D2receptor heteromerization in schizophrenia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance

Stefan P. Brugger et al.

BIOLOGICAL PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

Revealing Adenosine A(2A)-Dopamine D-2 Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay

Victor Fernandez-Duenas et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders

Maria Rosaria Domenici et al.

PHARMACOLOGICAL RESEARCH (2019)

Article Behavioral Sciences

Behavioral control by striatal adenosine A2A-dopamine D2 receptor heteromers

J. Taura et al.

GENES BRAIN AND BEHAVIOR (2018)

Review Biochemistry & Molecular Biology

Purinergic system in psychiatric diseases

A. Cheffer et al.

MOLECULAR PSYCHIATRY (2018)

Article Clinical Neurology

Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology

P. Andres-Benito et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)

Review Pharmacology & Pharmacy

Caffeine-induced psychiatric manifestations: a review

Hee Ryung Wang et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2015)

Article Multidisciplinary Sciences

Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

Jordi Bonaventura et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Psychiatry

Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain

N. D. Volkow et al.

TRANSLATIONAL PSYCHIATRY (2015)

Article Medicine, General & Internal

Schizophrenia

Rene S. Kahn et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Psychiatry

Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia

Izaskun Villar-Menendez et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2014)

Review Clinical Neurology

Schizophrenia and dopamine receptors

Philip Seeman

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)

Article Clinical Neurology

Are dopamine D2 receptors out of control in psychosis?

Philip Seeman

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)

Review Psychiatry

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

Oliver D. Howes et al.

ARCHIVES OF GENERAL PSYCHIATRY (2012)

Article Neurosciences

Adenosine hypothesis of schizophrenia - Opportunities for pharmacotherapy

Detlev Boison et al.

NEUROPHARMACOLOGY (2012)

Review Pharmacology & Pharmacy

Animal models of schizophrenia

C. A. Jones et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Review Pharmacology & Pharmacy

Targeting the dopamine D2 receptor in schizophrenia

Philip Seeman

EXPERT OPINION ON THERAPEUTIC TARGETS (2006)

Review Medicine, General & Internal

Schizophrenia

R Freedman

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Behavioral Sciences

Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor

JH Wang et al.

BEHAVIOURAL BRAIN RESEARCH (2003)

Review Medicine, Research & Experimental

Schizophrenia: a purinergic hypothesis

DR Lara et al.

MEDICAL HYPOTHESES (2000)